Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

vTv Therapeutics (VTVT) Research & Development: 2013-2024

Historic Research & Development for vTv Therapeutics (VTVT) over the last 12 years, with Dec 2024 value amounting to $11.5 million.

  • vTv Therapeutics' Research & Development rose 117.74% to $7.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.2 million, marking a year-over-year increase of 41.37%. This contributed to the annual value of $11.5 million for FY2024, which is 15.07% down from last year.
  • Per vTv Therapeutics' latest filing, its Research & Development stood at $11.5 million for FY2024, which was down 15.07% from $13.6 million recorded in FY2023.
  • vTv Therapeutics' 5-year Research & Development high stood at $13.6 million for FY2023, and its period low was $11.0 million during FY2020.
  • In the last 3 years, vTv Therapeutics' Research & Development had a median value of $12.4 million in 2022 and averaged $12.5 million.
  • Per our database at Business Quant, vTv Therapeutics' Research & Development decreased by 27.14% in 2020 and then rose by 20.96% in 2021.
  • vTv Therapeutics' Research & Development (Yearly) stood at $11.0 million in 2020, then climbed by 20.96% to $13.3 million in 2021, then dropped by 7.26% to $12.4 million in 2022, then grew by 10.02% to $13.6 million in 2023, then declined by 15.07% to $11.5 million in 2024.